Metabolic and Pharmacokinetic Investigation
Antibiotic-treated Rats Di Cao1, Zhengjiao Wang1, Xiuting Shen2, Xiaojun Song1, Zhongxiang Zhao2★★ Corresponding author
- 1School of Chinese Materia Medica, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, CHINA.
- 2School of Pharmacy, Wannan Medical College, Wuhu, Anhui, China.
CORRESPONDENCE
Zhongxiang Zhao
School of Pharmacy, Wannan Medical College, Wuhu, Anhui, China.
Received: 24-04-2023; Accepted: 25-07-2023.
Volume 20, Issue 1 · pp. 245–256 · PUBLISHED 2024 · DOI: 10.1177/09731296231198608
View on Pharmacogn. Mag. original site ↗
ABSTRACT
Background: Ilexsaponin A1 (IA1) is a bioactive triterpene saponin derived from natural medicinal plants. IA1 exhibits antiinflammatory and proangiogenic activities and improves intestinal barrier function. It has been reported that IA1 could be metabolized into a dominant metabolite, ilexgenin A (IA) by β-glucosidase enzymes in intestinal microflora. Materials and Methods: Herein, an accurate, sensitive, and selective method based on ultra-performance liquid chromatography coupled with mass spectrometry was established to simultaneously profile the metabolism and pharmacokinetic behaviors of IA1 in normal and antibiotic-treated rat plasma after intragastric administration of IA1. The precursor-to-product ion pairs of IA and IA1 were m/z 501.32→439.32 and m/z 663.38→501.32, respectively. For method validation, the specificity, matrix effect, accuracy, precision, and stability of the pharmacokinetic study were measured, and a calibration curve was created. The collaborative pharmacological target pathways of IA1 and its metabolite IA were investigated using network pharmacology tools. Results: The validated analytical method was successfully utilized to investigate the pharmacokinetics of IA1 in normal and antibiotic-treated rats. The bioavailability of IA1 and conversion from IA1 to IA were significantly inhibited by antibiotic-treated rats after oral administration of IA1. Fragment ions at m/z 483.3155, 455.3159, 439.3233, 421.3136, 395.3362, 152.9952, 113.0256, and 71.0531 were characteristic of the IA1 moiety. IA1 was metabolized in rat plasma by biotransformation routes involving deglycosylation, decarboxylation, isomerization, hydrogenation, dehydrogenation, and oxidation. Considering database analysis, IA and IA1 play synergistic role in common pharmacological pathways, such as hypertrophic cardiomyopathy and dilated cardiomyopathy. Conclusion: The experiments illustrated that β-glucosidase activity inhibited by antibiotics suppressed the hydrolysis reaction of IA1 in the intestinal tract. IA1 and IA play a synergistic role in exerting effects.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Cao, A. R. D., Wang, Z., Shen, X., Song, X., & Zhao, Z. (2024). Metabolic and Pharmacokinetic Investigation. Pharmacognosy Magazine, 20(1), 245–256. https://doi.org/10.1177/09731296231198608